TY - JOUR
T1 - Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates
AU - Del Mar Tavío, María
AU - Vila, Jordi
AU - Ruiz, Joaquím
AU - Ruiz, José
AU - Martín-Sánchez, Antonio Manuel
AU - Jiménez De Anta, María Teresa
PY - 1999
Y1 - 1999
N2 - Eighteen quinolone-resistant isolates of Escherichia coli were selected by exposing ten clinical isolates to increasing concentrations of norfloxacin and lomefloxacin. The mutant isolates showed a multiple-antibiotic-resistance phenotype. All of them contained single mutations in gyrA consisting of the substitution of Ser-83→Leu (n = 14), Val (n = 1) or Ala (n = 1) and the substitution of Asp-87→Asn (n = 2). Only one concomitant mutation in parC (Ser-80→Arg) was detected. Four parent isolates exhibited a single mutation in gyrA which required ≤ 1 mg/L of norfloxacin to be inhibited. Fluoroquinolone resistance, in the 18 quinolone-resistant mutants, was a result of mutations affecting DNA gyrase plus decreased fluoroquinolone uptake. This latter mechanism of resistance was a combined effect of an absence of OmpF and an increase in active efflux in eight isolates, or an increased active efflux alone in the remaining ten selected mutants.
AB - Eighteen quinolone-resistant isolates of Escherichia coli were selected by exposing ten clinical isolates to increasing concentrations of norfloxacin and lomefloxacin. The mutant isolates showed a multiple-antibiotic-resistance phenotype. All of them contained single mutations in gyrA consisting of the substitution of Ser-83→Leu (n = 14), Val (n = 1) or Ala (n = 1) and the substitution of Asp-87→Asn (n = 2). Only one concomitant mutation in parC (Ser-80→Arg) was detected. Four parent isolates exhibited a single mutation in gyrA which required ≤ 1 mg/L of norfloxacin to be inhibited. Fluoroquinolone resistance, in the 18 quinolone-resistant mutants, was a result of mutations affecting DNA gyrase plus decreased fluoroquinolone uptake. This latter mechanism of resistance was a combined effect of an absence of OmpF and an increase in active efflux in eight isolates, or an increased active efflux alone in the remaining ten selected mutants.
UR - http://www.scopus.com/inward/record.url?scp=0032805684&partnerID=8YFLogxK
U2 - 10.1093/jac/44.6.735
DO - 10.1093/jac/44.6.735
M3 - Artículo
C2 - 10590273
AN - SCOPUS:0032805684
SN - 0305-7453
VL - 44
SP - 735
EP - 742
JO - Journal of Antimicrobial Chemotherapy
JF - Journal of Antimicrobial Chemotherapy
IS - 6
ER -